Keith Harshman
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Cutaneous Melanoma Detection and Management
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Gene expression and cancer classification 4
- RNA Research and Splicing 3
- Molecular Biology Techniques and Applications 3
- Genetics 8
- Virus-based gene therapy research 3
- Co-authors
- Mark H. Skolnick (3 shared papers)Sean V. Tavtigian (3 shared papers)Alexander Kamb (3 shared papers)Qingyun Liu (2 shared papers)Rufus S. Day (1 shared paper)Nelleke A. Gruis (1 shared paper)Jane Weaver-Feldhaus (1 shared paper)Elisabeth Stockert (1 shared paper)
- Journals
- Nucleic Acids Research (5 papers)BioTechniques (2 papers)Journal of Virology (2 papers)Eukaryotic Cell (2 papers)Science (2 papers)
- Partner nations
- SwitzerlandUnited StatesSpain
In The Last Decade
Keith Harshman
40 papers receiving 4.7k citations
Keith Harshman's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 1.8k
- Cancer Research 847
- Molecular Biology 2.7k
- Aging 51
- Cell Biology 419
Countries citing papers authored by Keith Harshman
This map shows the geographic impact of Keith Harshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Harshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Harshman more than expected).
Fields of papers citing papers by Keith Harshman
This network shows the impact of papers produced by Keith Harshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Harshman. The network helps show where Keith Harshman may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Harshman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types Hit paper breakdown → | 1994 | 2425 |
| 2 | 2011 | 313 | |
| 3 | 1988 | 218 | |
| 4 | 1985 | 209 | |
| 5 | 2012 | 153 | |
| 6 | 2009 | 153 | |
| 7 | 1990 | 146 | |
| 8 | 2003 | 112 | |
| 9 | 2003 | 104 | |
| 10 | 2013 | 100 | |
| 11 | 2010 | 88 | |
| 12 | 1994 | 85 | |
| 13 | 2009 | 75 | |
| 14 | 2004 | 73 | |
| 15 | 2008 | 66 | |
| 16 | 2005 | 53 | |
| 17 | 2011 | 48 | |
| 18 | 2000 | 42 | |
| 19 | 2012 | 42 | |
| 20 | 2016 | 39 |
About Keith Harshman
Keith Harshman is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Immunology, having authored 40 papers that have together received 4.9k indexed citations. Recurring topics across this work include Gene expression and cancer classification (4 papers), RNA Research and Splicing (3 papers), Nail Diseases and Treatments (3 papers), Plant Pathogens and Fungal Diseases (3 papers), Molecular Biology Techniques and Applications (3 papers), Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (847 citations), Molecular Biology (2.7k citations), Aging (51 citations) and Cell Biology (419 citations). Keith Harshman has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Mark H. Skolnick, Sean V. Tavtigian, Alexander Kamb, Qingyun Liu, Rufus S. Day, Nelleke A. Gruis, Jane Weaver-Feldhaus, Elisabeth Stockert, Bruce Evan Johnson and Peter B. Dervan. Their work appears in journals such as Nucleic Acids Research, BioTechniques, Journal of Virology, Eukaryotic Cell and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.